OncoMed Pharmaceuticals Inc - FORM S-1/A - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - October 24, 2012

Attached files

file filename
S-1/A - AMENDMENT NO. 4 TO REGISTRATION STATEMENT ON FORM S-1 - OncoMed Pharmaceuticals Incd344523ds1a.htm
EX-10.20 - COLLABORATION AGREEMENT - OncoMed Pharmaceuticals Incd344523dex1020.htm
EX-10.1(C) - SECOND AMENDMENT REGARDING PAYMENT OF CERTAIN MILESTONE PAYMENTS - OncoMed Pharmaceuticals Incd344523dex101c.htm
EX-10.21 - MULTI-PRODUCT LICENSE AGREEMENT - OncoMed Pharmaceuticals Incd344523dex1021.htm
EX-10.2(B) - AMENDMENT 1 TO THE COLLABORATION AND OPTION AGREEMENT - OncoMed Pharmaceuticals Incd344523dex102b.htm

Exhibit 23.1

Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm

We consent to the reference to our firm under the caption “Experts” and to the use of our report dated May 11, 2012, in Amendment No. 4 to the Registration Statement (Form S-1 No. 333-181331) and related Prospectus of OncoMed Pharmaceuticals, Inc. for the registration of shares of its common stock.

/s/ Ernst & Young LLP

Redwood City, California

October 24, 2012

OncoMed Pharmaceuticals Inc Reports